A meta-analysis [74] including the ELIXA [66], LEADER [44], SUSTAIN-6 [67], EXSCEL [68], REWIND [70], and AMPLITUDE-O [51] studies found that GLP-1RAs were associated with better renal outcomes: a 30% or 40% or more decrease in glomerular filtration rate, need for renal replacement therapy, end-stage renal failure, or death from kidney disease by 21%
"It's a very complex discussion
GLP-1 regulates blood sugar, slows digestion, and signals fullness to the brain
Two people who start at the same point may never reach the same later stage, since the pace and ceiling of any plan depend on individual response rather than a shared target
The distinction matters because short-term therapy teaches your body to suppress appetite temporarily, while extended therapy retrains your appetite regulation systems more durably
adult population, up from just 0.93 percent and 4.4 percent in 1958 and 2000, respectively